Detection and Characterization of Emerging Vector-Borne and Zoonotic Pathogens in Indonesia

The summary for the Detection and Characterization of Emerging Vector-Borne and Zoonotic Pathogens in Indonesia grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Detection and Characterization of Emerging Vector-Borne and Zoonotic Pathogens in Indonesia: The purpose of this Notice of Funding Opportunity (NOFO) is to support research to enable rapid and accurate identification of emerging vector-borne and zoonotic threats in Indonesia by building upon the scientific and laboratory infrastructure established under two previously awarded NOFOs. Indonesia is a recognized “hotspot” for emerging pathogens. It is the world's fourth largest population, spread among nearly 1000 inhabited islands stretching 3,400 miles along the equator, making opportunities for an emerging pathogen to become epidemic in the absence of a reliable detection system high. The arthropod-borne viruses (arboviruses) and Rickettsia (typhus and spotted fevers) are of particular concern because of the ease with which vectors can transfer these viruses between wildlife, humans and livestock. Remarkably, little is known about these diseases in Indonesia or their potential for movement within and from the country. For example, only two of 11 pathogenic arboviruses known to be found in neighboring Australia have been identified in Indonesia. Although Indonesia is known historically to be endemic for murine typhus and scrub typhus, they are almost never diagnosed. CDC began a highly successful effort to build Indonesian capacity to identify emerging vector-borne diseases in 2011. This effort helped to (1) build and support a state-of-the-art molecular diagnostic laboratory at Jakarta; (2) conduct countrywide training in virological techniques and biosafety; and (3) pilot a large-scale acute febrile illness (AFI) surveillance network. During the previous cooperative agreement (RFA-CK-15-001), Indonesian and CDC partners identified the first West Nile and Zika virus cases in Indonesia, conducted the first Zika seroprevalence study, and identified Rickettsia felis for the first time as a cause of fatal neurological disease. Indonesia is a leader of the Global Health Security Agenda and the CDC mission supports Indonesia's efforts to fulfill its Joint External Evaluation (JEE) goals; especially strengthening the national laboratory system and improving the ability of real-time surveillance in detecting emerging pathogens (WHO/OHE/2016.4, Indonesia JEE, November 2017).
Federal Grant Title: Detection and Characterization of Emerging Vector-Borne and Zoonotic Pathogens in Indonesia
Federal Agency Name: Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CK-20-002
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.084
CFDA Descriptions: Information not provided
Current Application Deadline: January 14th, 2020
Original Application Deadline: January 14th, 2020
Posted Date: October 19th, 2019
Creation Date: October 19th, 2019
Archive Date: February 13th, 2020
Total Program Funding: $5,000,000
Maximum Federal Grant Award: $1,000,000
Minimum Federal Grant Award: $300,000
Expected Number of Awards: 1
Cost Sharing or Matching: No
Last Updated: October 19th, 2019
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
ALERT Asia Foundation/Eijkman Institute for Molecular Biology (EIMB) is eligible to apply for this NOFO.
Grant Announcement Contact
Amy Yang
vdz9@cdc.gov
Grants Policy
Similar Government Grants
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance ...
Monitoring Cause-specific School Absenteeism for Estimating Community-wide Influenza and S...
US Travelers Health Research, Surveillance, Communication, and Outreach Network
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travelers w...
Reducing the burden of parasitic infections in the United States through evidence-based pr...
Impact of Japanese Encephalitis Vaccination in Cambodia
Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...
Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention ERA
Modeling Infectious Diseases in Healthcare Research Projects to Improve Prevention Researc...
Enhanced Surveillance and Control of Arboviruses in Puerto Rico
Network of Modeling Centers to Improve Evidence Base for Seasonal and Pandemic Influenza P...
Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in P...
Multi-Site Study of the Health Implications of Exposure to PFAS-Contaminated Drinking Wate...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020 FederalGrants.com